Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Improved Detection of Lung Cancer Nodules with CAD Chest X-Ray Technology

By HospiMedica International staff writers
Posted on 07 Mar 2011
A new study revealed that radiologists using a computer-aided detection (CAD) system were able to detect smaller lung nodules, including those that were primary lung cancer. More...


Riverain Medical (Dayton, OH, USA), a developer of CAD and advanced visualization technologies, announced the study's findings that have been published on the European Society of Radiology's website (please see related links below). Investigators compared two versions of Riverain Medical's CAD technology, OnGuard 5.1 and OnGuard 1.0.

"By using OnGuard 5.1 in tandem with a standard chest X-ray, our radiologists are now able to detect smaller lung nodules that would have previously gone unnoticed," said Dr. Matthew Freedman, lead investigator of the study and associate professor of oncology at the Lombardi Comprehensive Cancer Center at Georgetown University (Washington DC, USA). "It's clear from our research that OnGuard CAD technology has improved significantly over the past 10 years. Improved sensitivity and a lower false positive rate allow radiologists to detect early-stage lung cancer sooner, giving them more confidence in diagnosing the patient."

Fifteen radiologists participated in the reader study, which analyzed more than 250 chest X-rays (approximately a 2:1 cancer negative to positive ratio). Compared to its earlier version, investigators found OnGuard 5.1 provided nearly 50% higher machine sensitivity for cancer detection, while significantly reducing the number of false positives per image.

"Initial results of the National Lung Screening Trial demonstrate for the first time that the early detection of lung cancer can save lives," said Steve Worrell, chief technology officer of Riverain Medical. "We're excited to play a key role in the early detection of lung cancer. OnGuard's CAD markings give radiologists a second set of eyes, allowing radiologists to find cancerous nodules at their earliest and most treatable stage."

The European Society of Radiology's annual meeting, ECR [European Congress of Radiology] 2011, will take in Vienna, Austria from March 3-7, 2011.

Related Links:
Riverain Medical
European Society of Radiology
Georgetown University


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Premium Air-Mattress
MA-51
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.